In a time of intense disruption, organizations across the life sciences and medical device industries must balance a wide range of costly dynamics. Funding, product commercialization, research and development, regulatory compliance, and process scaling and optimization are all capital-intensive activities. On top of that, organizations need to keep pace with the new health economy while pivoting to value-based payment models and changing patient and customer needs.
Whether you’re expanding globally, optimizing tax incentives, executing an acquisition transaction, or looking to improve your current operations, we have a deep and diverse bench of tax, audit, and consulting experts to help. Our team provides proactive insights and pragmatic ideas to increase your bottom line and deliver better patient outcomes.
We serve bioscience, medical device, pharmaceutical, and life sciences clients of all sizes and structure from prerevenue startups to public companies with billons in annual revenue, as well as nonprofit research and incubator organizations. When it comes to critical issues, we don’t take shortcuts — we take action.
